Evidera, PPD’s evidence, value & access business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products. We help companies generate the evidence needed to optimize the market access and commercial potential of their products, including the special expertise required to support the unique challenges faced by precision and transformative technologies.
We provide integrated and tailored scientific expertise and global operational capabilities. Our offerings include interventional studies, real-world observational research and data analytics, patient-centered outcomes studies, epidemiological studies, modeling and simulation, meta-analysis, literature reviews, market access consulting and communications, and medical writing.
Evidera has approximately 500 employees representing over 35 nationalities in locations around the world, with major offices across North America and Europe. Our staff are methodological and thought leaders with an average of 15 years of experience, contributing to hundreds of submissions to payers and regulators, and publishing over 2,200 peer-reviewed articles dating back 30 years.